Evidence map›Paper›PMID 36932053›Full record

ArticleChemMedChem2023

Synthesis and Biological Activities of 11- and 12-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.

Hao Yang, Chao Qin, Min Wu, Fang-Ting Wang, Wenjie Wang, Keli Agama, Yves Pommier, De-Xuan Hu, Lin-Kun An

Open access · greenAbstract read
In one paragraph

Article in ChemMedChem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Hao YangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China.ORCID 0000-0001-5351-1806
Chao QinSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China.
Min WuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China.
Fang-Ting WangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China.
Wenjie WangDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Keli AgamaDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Yves PommierDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
De-Xuan HuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China.
Lin-Kun AnSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China.ORCID 0000-0002-6088-1503
Sun Yat-sen University · CNNational Institutes of Health · US

Funding

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer DrugsZIABC006150 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 2009 to 2025
$23.0M
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITIONZ01BC006150 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 1996 to 2008
$1.5M
Intramural NIH HHS Z01 BC006150
6 · The paper itself

Abstract

Herein, a series of 11- or 12-substituted benzophenanthridinone derivatives was designed and synthesized for the discovery of dual topoisomerase IB (TOP1) and tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors. Enzyme-based assays indicated that two compounds 12 and 38 showed high TOP1 inhibitory potency (+++), and four compounds 35, 37, 39 and 43 showed good TDP1 inhibition with IC

Indexed as

DNA Topoisomerases, Type IPhosphodiesterase InhibitorsHumansPhosphoric Diester HydrolasesTopoisomerase I InhibitorsTopotecanDNA Topoisomerases, Type IPhosphodiesterase InhibitorsPhosphoric Diester HydrolasesTDP1 protein, humanTopoisomerase I InhibitorsTopotecantyrosyl-DNA phosphodiesteraseanticancer agentsDNA repairinhibitorstopoisomerasetyrosyl-DNA phosphodiesterase

Identifiers

PMID36932053
PMCPMC10233710
OpenAlexW4327811292

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.